4-chloro-2-morpholino-1,3-thiazole-5-carbonitrile | 1202042-08-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-chloro-2-morpholino-1,3-thiazole-5-carbonitrile
• 英文别名: 4-chloro-2-morpholin-4-yl-1,3-thiazole-5-carbonitrile
• CAS: 1202042-08-7
• 化学式: C₈H₈ClN₃OS
• 分子量: 229.69
• InChiKey: OPHVCGXUPZZCBD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  77.4
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-chloro-2-morpholino-1,3-thiazole-5-carbonitrile 在 bis-triphenylphosphine-palladium(II) chloride 硫酸 、 水 、 sodium carbonate 作用下， 以 乙二醇二甲醚 、 乙醇 、 水 为溶剂， 反应 2.0h， 生成
  参考文献：
  名称：

  [EN] THIOPHENE OR THIAZOLE DERIVATIVES AND THEIR USE AS PI3K INHIBITORS
  [FR] DÉRIVÉS DE THIOPHÈNE OU DE THIAZOLE ET LEUR UTILISATION COMME INHIBITEURS DE PI3K

  摘要：

  公开号：

  WO2009154741A8
• 作为产物：
  描述：

  4-amino-2-(4-morpholinyl)-1,3-thiazole-5-carbonitrile 在 亚硝酸特丁酯 、 copper dichloride 作用下， 以 乙腈 为溶剂， 以52%的产率得到4-chloro-2-morpholino-1,3-thiazole-5-carbonitrile
  参考文献：
  名称：

  4-Bromo-2-(piperidin-1-yl)thiazol-5-yl-phenyl methanone (12b) inhibits Na+/K+-ATPase and Ras oncogene activity in cancer cells

  摘要：

  The in vitro growth inhibitory activity of 26 thiazoles (including 4-halogeno-2,5-disubtituted-1,3-thiazoles) and 5 thienothiazoles was assessed on a panel of 6 human cancer cell lines, including glioma cell lines. (4-Chloro-2-(piperidin-1-yl)thiazol-5-yl)(phenyl)methanone (12a) and (4-bromo-2-(piperidin-1-yl)thiazol-5-yl)(phenyl)methanone (12b) displayed similar to 10 times greater in vitro growth inhibitory activity than perillyl alcohol (POH), which therapeutically benefits glioma patients through the inhibition of both alpha-1 Na+/K+-ATPase (NAK) and Ras oncogene activity. The in vitro cytostatic activities (as revealed by quantitative videomicroscopy) displayed by 12a and 12b were independent of the intrinsic resistance to pro-apoptotic stimuli associated with cancer cells. Compounds 12a and 12b displayed relatively similar inhibitory activities on purified guinea pig brain preparations that mainly express NAK alpha-2 and alpha-3 subunits, whereas only compound 12b was efficacious against purified guinea pig kidney preparations that mainly express the NAK alpha-1 subunit, which is also expressed in gliomas, melanomas and non-small-cell lung cancers NSCLCs. (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.01.046

文献信息

• Heteroaryls and uses thereof
  申请人：Cardin David P.

  公开号：US20100075951A1

  公开（公告）日：2010-03-25

  This invention provides compounds of formula I: wherein R 1 , R 2 , CY, Y 1 , Y 2 , X 1 , X 2 , and X 3 are as described in the specification. The compounds are inhibitors of PI3K and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.

  本发明提供了式I的化合物：其中R1、R2、CY、Y1、Y2、X1、X2和X3如说明书所述。这些化合物是PI3K的抑制剂，因此用于治疗增殖性、炎症性或心血管疾病。
• HETEROARYLS AND USES THEREOF
  申请人：Cardin David P.

  公开号：US20120202812A1

  公开（公告）日：2012-08-09

  This invention provides compounds of formula I: wherein R 1 , R 2 , CY, Y 1 , Y 2 , X 1 , X 2 , and X 3 are as described in the specification. The compounds are inhibitors of PI3K and are thus useful for treating proliferative, inflammatory, or cardiovascular disorders.

  本发明提供了式I的化合物：其中R1，R2，CY，Y1，Y2，X1，X2和X3如规范中所述。这些化合物是PI3K的抑制剂，因此可用于治疗增殖性、炎症性或心血管疾病。
• THIOPHENE OR THIAZOLE DERIVATIVES AND THEIR USE AS PI3K INHIBITORS
  申请人：MILLENNIUM PHARMACEUTICALS, INC.

  公开号：EP2313399B1

  公开（公告）日：2014-05-28
• US8183240B2
  申请人：——

  公开号：US8183240B2

  公开（公告）日：2012-05-22
• US8440664B2
  申请人：——

  公开号：US8440664B2

  公开（公告）日：2013-05-14